CapMan Growth has agreed to sell its stake in Silmäasema, Finland's largest operator in private eye care and optical retail, for €574 million enterprise value. Terveystalo will pay €275 million in cash plus 36.5 million new shares to complete the transaction.

During CapMan's ownership, Silmäasema's revenue grew at 16% per year, more than doubling to €267 million. The Finnish eye health company has expanded significantly under private equity backing, consolidating its position in the Nordic optical market.

The exit represents CapMan Growth's tenth deal exit and the second for its Growth Equity II fund. The transaction highlights active dealmaking in Nordic healthcare assets, with private equity firms continuing to capitalize on strong growth in specialized healthcare services.